Likewise, we also observed significant up-regulation of the regulatory NLRs associated with pro-inflammatory signaling, including NOD1, NOD2, and CIITA (NLRA) signaling in patients with active CeD (Figure 1B; Supplemental Figure 1). The gene discussed is NOD2; the disease is cranioectodermal dysplasia.